Physician Marketing 2025

Pharma Doctor Outreach Rises as D2C Drug Ads Face Scrutiny

Tougher D2C ad regulations will push pharma to rely more on doctors for patient drug education and prescription growth. This report examines how pharma marketers can more effectively use digital tools and channels to create credible engagement strategies that offset decreased consumer exposure.

Key Question: How are physician preferences for pharma content consumption evolving, and how can marketers use digital tools to better engage them?

Key Stat: Healthcare and pharma marketers will spend $2.11 billion on B2B digital ad spending in 2025, up 10.7% YoY, reaching $2.54 billion by 2027.

Here’s what’s in the full report

1file

Exportable files for easy reading, analysis and sharing.

7charts

Reliable data in simple displays for presentations and quick decision making.

4expert perspectives

Insights from industry and company leaders.

    Table of Contents

    1. Executive Summary
    2. With D2C drug advertising in flux, pharma must strengthen HCP outreach
    3. Drugmakers must adapt to HCPs’ online behaviors and preferred channels for receiving medical information
    1. Hyperefficient, digital-first strategies counteract declining HCP access
    2. Recommendations for marketers
    3. EMARKETER Interviews
    1. Sources
    2. Media Gallery

    Interviewed for This Report

    Ian Essling
    CMI Media Group
    Director, Audience Intelligence
    Interviewed September 30, 2025
    Manoj Hariharaputhiran
    ZoomRx
    Project Manager
    Interviewed September 15, 2025
    Jay Schwartz
    Indegene
    Vice President, Customer Engagement Omnichannel
    Interviewed October 3, 2025
    Sarah Tomalavage
    CMI Media Group
    Group Senior Vice President, Engagement Strategy
    Interviewed September 30, 2025

    Access All Charts and Data

    Gain access to reliable data presented in clear and intelligible displays for quick understanding and decision making on the most important topics related to your industry, included at no extra cost.

    authors

    Rajiv Leventhal

    Contributors

    Beth Snyder Bulik
    Eleni Digalaki
    Nikolai Dineros
    Donte Gibson
    Senior Charts Editor
    Jennifer Pearson
    VP, Research
    Heather Sprung
    Senior Editor
    Emman Velasco
    Chart Editor
    Paul Verna
    VP, Content